Back
OncoCyte Stock Price Chart
Sponsored
OCX
Sponsored
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
34
OCX
OncoCyte
Last Price:
2.85
Seasonality Move:
-8.75%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.
OncoCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.92 | Sell |
20-day SMA: | 3.03 | Sell |
50-day SMA: | 3.07 | Sell |
200-day SMA: | 2.96 | Sell |
8-day EMA: | 2.95 | Sell |
20-day EMA: | 3 | Sell |
50-day EMA: | 3.04 | Sell |
200-day EMA: | 3.31 | Sell |
OncoCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 43.82 | Sell |
Chaikin Money Flow: | -5912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.93 - 3.17) | Sell |
Bollinger Bands (100): | (2.8 - 3.18) | Sell |
OncoCyte Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OncoCyte Stock
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.89 while OCX 8-day simple moving average is 2.92, which is a Sell signal.
- The stock price of OCX is 2.89 while OncoCyte 20-day SMA is 3.03, which makes it a Sell.
- OncoCyte 50-day simple moving average is 3.07 while OCX share price is 2.89, making it a Sell technically.
- OCX stock price is 2.89 and OncoCyte 200-day simple moving average is 2.96, creating a Sell signal.
OCX Technical Analysis vs Fundamental Analysis
OncoCyte Stock Info
Market Cap:
38.63M
Price in USD:
2.89
Share Volume:
24.99K
OncoCyte 52-Week Range
52-Week High:
4.34
52-Week Low:
2.08
Sell
34
OncoCyte (OCX)
is a Sell
OncoCyte Share Price Forecast
-
What is the OncoCyte stock price today?
The OncoCyte stock price is 2.89 USD today. -
Will OCX stock go up or go down?
OncoCyte> share price is forecast to RISE/FALL based on technical indicators -
Is OncoCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.89 while OCX 8-day exponential moving average is 2.95, which is a Sell signal.
- The stock price of OCX is 2.89 while OncoCyte 20-day EMA is 3.00, which makes it a Sell.
- OncoCyte 50-day exponential moving average is 3.04 while OCX share price is 2.89, making it a Sell technically.
- OCX stock price is 2.89 and OncoCyte 200-day simple moving average is 3.31, creating a Sell signal.
Fundamental Analysis of OncoCyte
Is OncoCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of OncoCyte
Should I short OncoCyte stock?
- OCX Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting OncoCyte is a Sell
- OncoCyte Relative Strength Index (RSI) is 43.82, which suggest OncoCyte is oversold
- The Bollinger Bands (25) for OncoCyte is (2.93 - 3.17), which suggest OncoCyte is a Sell
- The Bollinger Bands (100) for OncoCyte is (2.8 - 3.18), which suggest OncoCyte is a Sell
* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.